FLT4 and breast carcinoma: So far, most of the studies have shown that FLT4 amplification primarily occurs in sAS, particularly those associated with radiation therapy for breast cancer or chronic lymphedema (28, 29, 44, 45), and always in association with MYC amplification (27, 29, 44, 45).